Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06254690
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2024-01-28
Brief Title:
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer a Phase II Clinical Study
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Organization Data
Organization:
The First Affiliated Hospital with Nanjing Medical University
Class:
OTHER
Study ID:
Photine
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Affiliated Hospital of Jiangsu University | OTHER |
| Zhongda Hospital | OTHER |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | OTHER |
| Jingjiang Peoples Hospital | OTHER |
| Yancheng First Peoples Hospital | OTHER |
| Affiliated Hospital of Jiangnan University | OTHER |
| Affiliated Hospital of Nantong University | OTHER |
| Anhui Provincial Cancer Hospital | OTHER |
| Huaian First Peoples Hospital | OTHER |
| The Affiliated Hospital of Xuzhou Medical University | OTHER |
| Suzhou Municipal Hospital | OTHER |